hVIVO contract the fruit of increasing Asian focus | News Direct

hVIVO contract the fruit of increasing Asian focus

hVIVO PLC
Digital Asset Direct by hVIVO PLC
Download PDF Download multimedia

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | January 04, 2023 08:37 AM Eastern Standard Time

hVIVO PLC (AIM:HVO) chief executive Mo Khan speaks to Proactive after announcing the signing of a £5.2mln contract with a biotech company in the Asia Pacific region to test the latter's respiratory syncytial virus (RSV) vaccine candidate. Khan says that the deal is the first hVIVO has signed in Asia in a decade, and is the result of the research company's increasing focus on growing its sales in the region

 

Contact Details

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com

DOWNLOAD

project media

Tags

HealthPharma & BiotechRespiratoryRSVVaccine
News Direct Logo
Follow us on Facebook Follow us on LinkedIn
Get the latest from News Direct
Contact Us Pricing
Why News Direct
About us Features News Hub
Resources
Terms of Use Privacy Policy
newsdirect.com © 2024 News Direct Corp. All rights reserved. News Direct is a registered trademark.